--2024/Q4-- / 8.634M--
Nov 7, 20242024/Q3-- / 7.856M--
Aug 8, 20242024/Q26.957M / 19.162M--
May 9, 20242024/Q128.935M / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 14.220
- -0.110-0.77%
Close Oct 31 16:00 ET
- 14.300
- +0.080+0.56%
Post 19:34 ET
1.44BMarket Cap-2594P/E (TTM)
14.520High13.950Low2.60MVolume14.250Open14.330Pre Close37.02MTurnover2.59%Turnover RatioLossP/E (Static)101.58MShares34.87052wk High1.49P/B1.43BFloat Cap13.95052wk Low--Dividend TTM100.30MShs Float202.730Historical High--Div YieldTTM3.98%Amplitude9.180Historical Low14.245Avg Price1Lot Size
Intellia Therapeutics Key Stats
Intellia Therapeutics Q3 2024 Estimates Date
Currency：USDNov 7, 2024
| Estimate | YoY | |
| Revenue | 7.86M | -34.49% |
| EPS | -1.39 | -0.38% |
Analyst Rating
Oct 31, 2024
Intellia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Intellia Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
